Wednesday, July 30, 2014

Top 10 Tech Companies To Watch For 2014

With shares of Corning (NYSE:GLW) trading around $19, is GLW an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Corning produces and sells specialty glasses, ceramics, and related materials worldwide. It operates in five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences. Corning has launched Corning Lotus Glass, an environmentally friendly display glass for organic LED and LCD displays that are used in portable devices such as smartphones, tablets, and notebook computers. Smart phones, tablets, notebook computers, and related materials are seeing explosive growth in developed and developing countries around the world.

An executive from Corning�took the stage at the Morgan Stanley Technology, Media, and Telecom Conference on Tuesday to say that the company�� Gorilla Glass is a better material to be used in consumer electronics than sapphire crystals. Rumors have been swirling that Apple (NASDAQ:AAPL) is planning to switch to sapphire for the display in the next iPhone, as the company has recently purchased a sapphire manufacturing plant in Arizona to make the scratch-resistant material.�Tony Tripeny, a senior vice president at Corning, spoke to analysts about the sapphire issue at the conference.

Top 5 China Stocks To Own Right Now: Vocus Inc.(VOCS)

Vocus, Inc. provides cloud marketing software that enables businesses attract, engage, and retain customers in the United States, Europe, Asia, and Morocco. It offers a suite of software for social media marketing, search marketing, email marketing, and publicity. The company?s cloud marketing solutions include search marketing and news distribution solution that helps customers increase their online visibility and organic search engine rankings with press releases; and email marketing solution, which provides a method of keeping in touch with prospects and customers by using professional looking emails to send newsletters, special offers, and other useful content. Its cloud marketing solutions also comprise social media software solution that helps customers run social marketing campaigns, as well as monitor and analyze conversations across multiple social networks and other online Websites; and publicity solution, which offers media database, news monitoring, and analyt ics and publicity opportunities that help companies increase their media exposure, manage relationships with reporters, and monitor and analyze trends unfolding in the media. The company also provides professional services that consist of data migration, custom development, and training. Vocus, Inc. sells its products to the financial and insurance, technology, healthcare and pharmaceutical, and retail and consumer products industries, as well as government agencies, not-for-profit organizations, and educational institutions through its direct sales channels, indirect sales channels, and the Internet. Vocus, Inc. was founded in 1988 and is headquartered in Beltsville, Maryland.

Advisors' Opinion:
  • [By Rich Smith]

    In a separate statement, the company announced a small change in management, bringing in ex-Vocus (NASDAQ: VOCS  ) Chief Operating Officer William R. Wagner to become its own COO. In an SEC filing, LogMeIn noted that it will pay Wagner $400,000 in annual base salary, plus:

Top 10 Tech Companies To Watch For 2014: Cytomedix Inc (CMXI)

Cytomedix, Inc. (Cytomedix), incorporated in April 29, 1998, is a regenerative therapies company marketing and developing products within the United States and internationally .The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company is a commercial operation, and a robust clinical pipeline representing a logical extension of its commercial technologies in the evolving field of regenerative medicine. Cytomedix primarily operates in the United States. Its commercial offerings are centered on its point of care platform technologies for the safe and efficient separation of blood and bone marrow to produce platelet based therapies or cell concentrates.

The Company markets and selsl two distinct platelet rich plasma (PRP) technologies, the AutoloGel System for wound care and the Angel concentrated Platelet Rich Plasma (cPRP) Sytem in orthopedic and cardiovascular markets. Its clinical pipeline includes the ALDH, which are cell-based therapies (Bright Cells). In February 2012, the Company acquired Aldagen, Inc.

The AutoloGel System

The AutoloGel System is a point of care device for the production of a platelet based bioactive therapy derived from a small sample of the patient�� own blood. Using the patient�� own platelets as a therapeutic agent, AutoloGel harnesses the body�� natural healing processes to deliver growth factors, chemokines and cytokines known to promote angiogenesis and to regulate cell growth and the formation of new tissue.

Angel Product Line

The Angel concentrated Platelet Rich Plasma (cPRP) System is a multi-functional cell separation device which produces concentrated platelet rich plasma for use in the operating room and clinic and is used in a range of orthopedic and cardiovascular indications. Similar to the AutoloGel System, the Angel System is a point of care device for the production of a concentrated, aseptic platelet! -based bioactive therapy derived from a small sample of the patient�� own blood. The resulting cPRP is applied at the site of injury to promote healing. The Angel product line also includes ancillary products such as phlebotomy and applicator supplies and activAT. activAT is designed to produce autologous thrombin serum from platelet poor plasma and is sold exclusively in Europe and Canada, where it provides a safe alternative to bovine-derived products.

ALDHbr Cell Technology and Development Pipeline

The ALDHbr (Bright Cell) technology is an approach to cell-based regenerative medicine and a logical extension of its commercial technologies in the evolving regenerative medicine market, with potential clinical indications in markets with unmet medical needs such as peripheral arterial disease and ischemic stroke. The Bright Cell technology is in that it utilizes an intracellular enzyme marker to facilitate fractionation of essential regenerative cells from a patient�� bone marrow. The bone marrow fractionation process identifies and isolates active stem and progenitor cells expressing high levels of the enzyme aldehyde dehydrogenase, or ALDH, which is a key enzyme involved in the regulation of gene activities associated with cell proliferation and differentiation.

The Company�� lead product candidate, ALD-401, is an autologous preparation of Bright Cells for the post-acute treatment of ischemic stroke. ALD-401 is being evaluated in the RECOVER-Stroke clinical study, an ongoing 100-patient, double-blind, placebo-controlled Phase 2 study in patients with unilateral, cerebral ischemic stroke with an NIH stroke scale score of less than 22. An additional product candidate, ALD-301, is in clinical development for peripheral arterial disease (PAD), a condition causing reduced flow of blood and oxygen to muscles in the leg. It has completed a Phase 1/2 study of autologous ALD-301 in critical limb ischemia (CLI), a late stage condition caused by PAD. The Phase 2 PACE! (Patient! s with Intermittent Claudication Injected with ALDH Bright Cells) study is an 80 patient, double-blind, placebo-controlled clinical trial intended to demonstrate the safety and efficacy of ALD-301 (Bright Cells) in patients diagnosed with IC.

The Company competes with Harvest Technologies (a subsidiary of Terumo), Biomet, Arteriocyte, and Arthrex.

Advisors' Opinion:
  • [By Bryan Murphy]

    When traders think of post-surgical wound management stocks, they may first think of names like Cytomedix, Inc. (OTCBB:CMXI) or Alliqua Inc. (OTCMKTS:ALQA). And well they should. Both companies have something of a history in the arena. ALQA is the purveyor of SilverSeal and Hydress antibiotic bandages, while CMXI is the developer of the AutoloGel system, which induces an affected patient's on body to do what it's supposed to do if there's a wound that won't heal. Cytomedix also makes the Angel platelet-rich plasma (PRP) delivery system. There's a relatively new name to add to the list of game-changing stocks in wound-management industry, however.... Arch Therapeutics Inc. (OTCBB:ARTH). The company is developing - well, has developed - a product called AC5 that nips post-surgical bleeding in the bud, largely negating the need for other post-surgical bleeding-control measures.

  • [By James E. Brumley]

    To give credit where it's due, Cytomedix, Inc. (OTCBB:CMXI) and Baxter International Inc. (NYSE:BAX) have both helped shape the landscape of the hemostasis (bleeding control) market with their products, AutoloGel and TISSELL, respectively. Arch Therapeutics Inc. (OTCBB:ARTH) has proverbially taken their concepts "up a notch", however, and its direct solution to a problem that CMXI and BAX can't quite solve may make ARTH the hottest trading candidate in the hemostasis space.

Top 10 Tech Companies To Watch For 2014: Silver Spring Networks Inc (SSNI)

Silver Spring Networks, Inc., incorporated on July 3, 2002, provides a networking platform and solutions that enable utilities to transform the power grid infrastructure into the smart grid. The Company�� networking platform provides two-way communications between the utility back office and devices on the power grid. In addition to its networking platform, it offers a suite of solutions that run on top of its network and complementary services, all of which is referred to as its Smart Energy Platform. Its service offerings include professional services to implement its products, managed services and software as a service ( SaaS), to assist utilities with managing the network and solutions, and ongoing customer support. Its Smart Energy Platform consists of hardware, software and services and combines with devices manufactured by third-party partners to form end-to-end smart grid offerings.

The Company�� solutions include advanced metering, which allows utilities to automate a number of manual processes and improve operational efficiencies, offer flexible pricing programs to consumers, and improve customer service with faster outage detection and restoration; distribution automation, which provides utilities with real-time visibility into the health of the grid, enabling better management and control of power distribution assets to improve grid reliability, and demand-side management, which enables utilities to offer consumers a variety of programs and incentives to use energy more efficiently and reduce usage at times of peak demand. The Company markets its Smart Energy Platform directly to utilities around the world. The Company�� network is composed of its hardware, such as access points and relays, its UtilOS network operating system, and GridScape software suite, which together provide utilities the ability to communicate with and control devices connected to the power grid.

The Company also offers a suite of solutions that run on top of its network, including ad! vanced metering, distribution automation, and demand-side management. These solutions include additional hardware, such as its communications modules and bridges, and applications from UtilityIQ and CustomerIQ software. Its solutions combine with devices from the large number of third parties with whom it collaborates to form end-to-end smart grid offerings built on its network. In addition, itoffers a range of services that enable its utility customers to deploy, operate and maintain its networking platform and solutions. These service offerings include professional services to implement its products, managed services and SaaS to assist utilities with managing the network and solutions, and ongoing customer support.

Advisors' Opinion:
  • [By John Udovich]

    Although small cap smart metering stock Silver Spring Networks Inc (NYSE: SSNI) recently soared on earnings, it also plunged yesterday�after loosing�out on important contract ��meaning it might be time to take a closer look at it along with other smart metering stocks like Itron, Inc (NASDAQ: ITRI) or Echelon Corporation (NASDAQ: ELON) to see if they are smart investments.

  • [By Jake L'Ecuyer]

    Equities Trading DOWN
    Shares of Silver Spring Networks (NYSE: SSNI) were down 23.66 percent to $17.91 after the company issued downbeat Q4 forecast. Credit Suisse downgraded the stock from Outperform to Neutral and cut the price target from $26.00 to $23.00.

  • [By Roberto Pedone]

    A technology stock that's quickly moving within range of triggering a big breakout trade is Silver Spring Networks (SSNI), which provides a networking platform and solutions that enable utilities to transform the power grid infrastructure into the smart grid. This stock has been on a hot streak over the last six months, with shares up by 22%.

    If you look at the chart for Silver Spring Networks, you'll notice that this stock has been uptrending strong for the last month and change, with shares moving higher from its low of $14.63 to its recent high of $22 a share. During that uptrend, shares of SSNI have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of SSNI within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in SSNI if it manages to break out above some near-term overhead resistance levels at $22 to $22.73 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 491,731 shares. If that breakout triggers soon, then SSNI will set up to re-test or possibly take out its next major overhead resistance levels at $23.90 to its gap down day high from August at $25.25 a share. Any high-volume move above $25.25 a share will then give SSNI a chance to re-fill some of that previous gap down zone that started near $32 a share.

    Traders can look to buy SSNI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $19.01 a share, or near $18 a share. One can also buy SSNI off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Tech Companies To Watch For 2014: Ebix Inc(EBIX)

Ebix, Inc. provides on-demand software and e-commerce solutions to the insurance industry. The company operates data exchanges, which connects multiple entities within the insurance markets and enables the participant to carry and process data from one end to another in the areas of life insurance, annuities, employee health benefits, risk management, workers compensation, and property and casualty (P&C) insurance. It is also involved in designing and deploying broker systems comprising three back-end systems consisting of eGlobal for multinational P&C insurance brokers; WinBeat for P&C brokers in the Australian and New Zealand markets; and EbixASP for the P&C insurance brokers in the United States. In addition, the company offers business process outsourcing services, which include certificate origination, certificate tracking, claims adjudication call center, and back office support. Further, it focuses on designing and deploying on-demand and back-end carrier systems, s uch as Ebix Advantage and Ebix Advantageweb targeted at small, medium, and large P&C carriers in the United States and internationally that operate in the personal, commercial, and specialty line areas of insurance. Additionally, Ebix, Inc. provides software development, customization, and consulting services to various companies in the insurance industry, such as carriers, brokers, exchanges, and standard making bodies. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:
  • [By John Reese]

    Indeed, in 2013, the Greenblatt-based portfolio has bounced back strong, returning more than 50%. Below is a look at its current holdings.

    EBIX, Inc. (EBIX)

    Western Refining (WNR)

    DirecTV (DTV)

    ITT Educational Services (ESI)

    Science Applications International (SAIC)

    Weight Watchers International (WTW)

    ConocoPhillips (COP)

    AmSurg Corp. (AMSG)

    PDL BioPharma (PDLI)

    AFC Enterprises (AFCE)

    Subscribe to Validea here��/p>

  • [By Roberto Pedone]

    One software player that's rapidly moving within range of triggering a big breakout trade is Ebix (EBIX), which provides a series of application software products for the insurance industry ranging from carrier systems, agency systems and exchanges to custom software development for all entities involved in the insurance and financial industries. This stock has been slammed hard by the bears so far in 2013, with shares off by 28%.

    If you look at the chart for Ebix, you'll notice that this stock has been uptrending for the last month, with shares moving higher from its low of $9.25 to its intraday high of $11.65 a share. During that uptrend, shares of EBIX have been consistently making higher lows and higher highs, which is bullish technical price action. That move is quickly pushing shares of EBIX within range of trigger a major breakout trade that could push the stock into a massive gap down zone from last June.

    Traders should now look for long-biased trades in EBIX if it manages to break out above some near-term overhead resistance levels at $11.74 to $12 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.06 million shares. If that breakout triggers soon, then EBIX will set up to re-fill some of its previous gap down zone from June that started near $20 a share. Some possible upside targets if EBIX gets into that gap with volume are $14 to $16 a share.

    Traders can look to buy EBIX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $10.87 a share or around more near-term support at $10.39 a share. One can also buy EBIX off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Tech Companies To Watch For 2014: IceWEB Inc (IWEB)

IceWEB, Inc. (IceWEB), incorporated in 1994, manufacture and market unified data storage, purpose built appliances, network and cloud attached storage solutions and deliver on-line cloud computing application services. The Company�� customer base includes the United States government agencies, enterprise companies, and small to medium sized businesses (SMB). The Company has three product offerings: Iceweb Unified Data Network Storage line of products, Purpose Built Network/Data Appliances and Cloud Computing Products/Services. In October 2013, IceWEB Inc completed its acquisition of Computers and Tele-Comm, Inc. and KC-NAP, LLC of Kansas City (collectively CTC).

IceWEB Unified Data Storage line of products

IceWEB is a provider of Unified Data Storage solutions. Its storage systems make it possible to operate and manage files and applications from a single device and consolidate file-based and block-based access in a single storage platform, which supports Fibre Channel SAN, IP-based SAN (iSCSI), and NAS (network attached storage). A unified storage system simultaneously enables storage of file data and handles the block-based I/O (input/output) of enterprise applications. One advantage of unified storage is reduced hardware requirements. The IceWEB Storage System is an all-inclusive storage management system, which includes de-duplication; unlimited snapshots; thin provisioning; local or remote, real-time or scheduled replication; capacity and utilization reporting, and integration with virtual server environments.

Purpose Built Network and Data Appliances

Purpose Built Network and Data Appliances are devices, which provide computing resources (processors and memory), data storage, and specific software for a specific application. The primary appliance products that IceWEB has built have been centered on a single large business partner, ESRI Corporation. IceWEB and ESRI have collaborated to create ultra-high performance IceWEB/ESRI GIS systems tha! t allow customers to access data with speed. ESRI Corporation takes responsibility for marketing to their customers and business partners, via their worldwide sales and consultancy organization.

Cloud Computing Products and Services

Cloud computing products and services consist of cloud computing services and cloud storage appliances. IceWEB provides IceMAIL, a packaged software service that provides network hosted groupware, e-mail, calendaring and collaboration functionality. Online services were expanded to include IcePORTAL, which provides customers with a complete Intranet portal and IceSECURE a hosted e-mail encryption service. Originally such hosted services were referred to as Software-as-a-Service (SaaS). Such services, hosted across the Internet are commonly referred to as Cloud Computing. A cloud storage appliance is a purpose built storage device configured for either branch office or central site deployment, which allows the housing and delivery of customer data across not only their internal networking infrastructure, but also to make that data available to employees or business partners securely via the Internet (often called the cloud).

The Company competes with EMC, Network Appliance, Dell, Hewlett-Packard, Sun Microsystems, Hitachi Data Systems, IBM, Compellent Technologies and Isilon.

Advisors' Opinion:
  • [By Peter Graham]

    What�� the Catch with Dephasium Corp? According to various disclosures, transactions of $2k, $2.5k, $3k, $4k, $7.5k, $12.5k and $15k have or will occur to mention Dephasium Corp in various investment newsletters. Dephasium Corp has been getting plenty of off and on attention for a couple of months now, but what�� been pretty strange is the company issuing a press release to announce that an unidentified third party, without the DPHS�� approval, has listed its shares on the Boerse Berlin Stock Exchange. The press release warned that this could be the first salvo in a ��ignificant naked shorting attack directed at the Company��given that the Berlin exchange is one of few stock exchanges in the world that allows listing and trading of a company's stock without the consent or authorization of the company being listed in order to facilitate short-selling. A quick look at Dephasium Corp�� financials reveals no revenues; net losses of $10k (most recent reported quarter), $17k and $11k plus net income of $388k; and $51k to cover $9k in current liabilities at the end of March. In other words, Dephasium Corp isn�� making money but someone else is trying to make some from it.

    IceWEB, Inc. (OTCBB: IWEB) Seems to Be Making Progress

    Small cap IceWEB is a provider of Unified Data Storage appliances for cloud and virtual environments, as well as the highly secure, scalable IceBOXTM BYOD (Bring Your Own Device) Private Digital Cloud Solution. On Friday, IceWEB fell 8.57% to $0.0320 for a market cap of $9.01 million plus IWEB is down 54.3% over the past year and down 81.7% over the past five years according to Google Finance.

Top 10 Tech Companies To Watch For 2014: Prosensa Holding NV (RNA)

Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company�� primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington�� disease. The Company�� clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company�� platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.

DMD is a rare, severe muscle wasting disease that occurs in up to 1 in 3,500 male births. It is commonly diagnosed between the ages of three to five, when boys begin to show signs of impaired motor development. PRO044, the Company�� product candidate, addresses a separate sub-population of DMD patients. The Company developed PRO044 using its exon-skipping technology to generate a product candidate with the same mechanism of action that is used by drisapersen.

Advisors' Opinion:
  • [By Leo Sun]

    However, these three biotech stocks -- Amarin (NASDAQ: AMRN  ) , Dendreon (NASDAQ: DNDN  ) , Prosensa (NASDAQ: RNA  ) -- don't fit that category at all. Read on to understand why these dogs of the sector should never be mistaken as underdogs.

  • [By Keith Speights]

    An "alley-oop" from the opponent
    Prosensa (NASDAQ: RNA  ) shares made something of a slam dunk this week, jumping more than 16%. That dunk was made with what amounts to an "alley-oop" from its primary rival, Sarepta Therapeutics (NASDAQ: SRPT  ) .

  • [By Bryan Murphy]

    Anybody who knows at least something about Prosensa Holding NV (NASDAQ:RNA) will at least know the stock turned into a disaster a few weeks ago, plunging from a close of $24.00 on September 19th to a close of $7.14 on September 20th, thanks to the failure of its MS drug drisapersen, which was jointly developed with GlaxoSmithKline plc (NYSE:GSK). Such is the life of a company with only one drug anywhere close to being approved; drisapersen was in Phase 3 trials - RNA shares could have just as easily gained 70% rather than lost 70% had the drug worked.

Top 10 Tech Companies To Watch For 2014: Rakuten Inc (RKUNF)

Rakuten Inc. is mainly engaged in the electronic commerce (EC) business and Internet-related businesses. The Internet Service segment operates Internet shopping mall Rakuten Ichiba, EC sites, travel reservation sites, portal sites, digital books, as well as sells advertisements and contents on these sites. The Internet Finance segment provides banking and securities services, credit cards related services, life insurance and electronic money services through Internets. The Others segment provides communication services and operates baseball teams. On March 27, 2013, the Company announced the completion of the acquisition of AIRIO, a life insurance company. On March 28, 2013, the Company acquired additional 61.29% stake of Stylife Corp. On October 15, 2013, the Company announced that it had acquired Spotlight Inc. On January 1, 2014, it transferred its online mall business Rakuten 24 to Kenko.com Inc. On February 3, 2014, it acquired the entire share capital of VI-VI-VI.COM Co., Ltd. Advisors' Opinion:
  • [By MARKETWATCH]

    LOS ANGELES (MarketWatch) -- Japanese stocks rose in early Monday trading, with weaker-than-expected trade data pushing the yen lower, which in turn helped some export stocks. The Nikkei Stock Average (JP:NIK) added 1% to 14,704.36, with the broader Topix up 0.8%, also enjoying support from gains Friday in the U.S. After data showing exports grew less than analysts had projected, the dollar (USDJPY) moved back above the 98-yen level, sending some exporters climbing, with a 2.2% rise for Fujitsu Ltd. (JP:6702) (FJTSY) , a 1.2% improvement for Alps Electric Co. (JP:6770) , and a 1% bump for Toyota Motor Corp. (JP:7203) (TM) . Shares of Suzuki Motor Corp. (JP:7269) (SZKMF) added 2.9% after a Nikkei report saying the company would record its highest-ever operating profit for the April-September half. Retailers were also a strong spot Monday, with J. Front Retailing Co. (JP:3086) up 2%, online marketplace Rakuten Inc. (JP:4755) (RKUNF) adding 2.4%, and 7-Eleven operator Seven & I Holdings Co. (JP:3382) (SVNDF) ahead by 1.4%.

  • [By MARKETWATCH]

    LOS ANGELES (MarketWatch) -- Japanese stocks slipped early Monday, with the Nikkei Stock Average (JP:NIK) down 0.1% at 14,298.17, and the Topix dropping 0.4%. Singapore-traded lead futures for the Nikkei Average had suggested a 0.8% gain for the index, but the indicator fell after the Cabinet Office reported fourth-quarter economic growth of 0.3%, flat from the previous quarter and below expectations in separate Reuters and Wall Street Journal/Nikkei surveys. The disappointing economic data also pushed the yen higher, weighing on some exporters, with Panasonic Corp. (JP:6752) (PCRFF) down 1.8%, NEC Corp. (JP:6701) (NIPNF) off 1.3%, and Sony Corp. (JP:6758) (SNE) down 0.7% after S&P downgraded the firm's credit rating to BBB- from BBB with a negative outlook. Shares of Internet retailer Rakuten Inc. (JP:4755) (RKUNF) dropped 12% after announcing plans to buy online messaging and telecom firm Viber Media Inc. for $900 million as well as posting below-consensus full-year profit. Banks were broadly lower, with Mizuho Financial Group Inc. (JP:8411) (MFG) off 1% and Sumitomo Mitsui Financial Group Inc. (JP:8316) (SMFG) off 1.1%, though Daiwa Securities Group Inc. (JP:8601)

No comments:

Post a Comment